Dermatology
Conference Coverage
Check all components in cases of suspected shoe allergy
Approximately 30% of patch tested patients with shoe allergies reacted to supplemental allergens.
Conference Coverage
Will psoriasis patients embrace proactive topical therapy?
Results of year-long PSO-LONG trial show superior efficacy, compared with conventional reactive management.
Conference Coverage
Contact allergen of the year found in foam in shin guards, footwear
The compound is likely not added intentionally, but is thought to result from reactions between additives during the manufacturing process.
From the Journals
Itch response faster with abrocitinib in trial comparing JAK inhibitor to dupilumab
At 2 weeks, half of the patients on 200 mg of abrocitinib had an itch response.
From the Journals
Vasodilatory medications found protective against rosacea
“We were very surprised to find that many of the agents we think of as vasodilators might actually be beneficial for rosacea.”
From the Journals
Is it possible to classify dermatologists and internists into different patterns of prescribing behavior?
“Future work is needed to identify underlying factors associated with different prescribing phenotypes among both dermatologists and internists...
From the Journals
Bacteriotherapy passes early test in phase 1 atopic dermatitis study
ShA9, a bacterium isolated from healthy human skin, was chosen as a potential topical therapy for AD based on its capacity both to...
Conference Coverage
Atopic dermatitis, sleep difficulties often intertwined
For the management of insomnia, try behavioral approaches first.
Conference Coverage
What drives treatment satisfaction among adults with atopic dermatitis?
Adults with AD and lower income, no health insurance, and multimorbidity had even lower treatment satisfaction.
Conference Coverage
Severe atopic dermatitis often puts a dent in quality of life
“There have been many surveys of adults with AD who report impairment of their sleep, reduced activity level, increased work absence, financial...
From the Journals
ACR, AAD, AAO, RDS issue joint statement on safe use of hydroxychloroquine
Four medical societies issued a joint statement on the low risk of retinopathy and risk factor management.